CSI Market
Sign In | Register

Alimera Sciences Inc (ALIM) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ALIM quarterly Cash Flow →
Cash flow data covering Alimera Sciences Inc–Dec 31 2019 offers a view into how Dec 31 2023's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
12 Months 		(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Operating Activities
Income-20.13
Depreciation & amortization8.75
Amortization of Other Assets1.02
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed2.51
Increase (Decrease) in Inventories-0.26
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation1.44
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized0.96
Increase Decrease In Fair Value Of Preferred Stock Conversion Feature-
Stock Compensation And Other-
Noncash Research And Development Expense-
Increase Decrease In Prepaid Expenses And Other Current Assets-
Increase Decrease In Accrued Expenses And Other Current Liabilities4.10
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature-
Ipo Issuance Costs Charged To Equity-
Non Cash Consideration Received As Revenue-
Change In Fair Value Of Warrant Asset0.13
Change In Fair Value Of Warrant Liability6.84
Income taxes0.03
Unrealized Gain (Loss) on Derivatives0.00
Increase (Decrease) in Accounts Receivable-17.16
Increase (Decrease) in Accounts Payable-1.88
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.72
Other Working Capital0.11
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-14.26
Investing Activities
Capital Expenditures-75.53
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-75.53
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-4.11
Long-term debt - borrowings22.50
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.91
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock77.68
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Exercise Of Common Stock Warrants-
Repayments Of Principal On Notes Payable-
Payment of Stock Issuance Costs Preferred Stock-
Payment Of Preferred Stock Exchange Costs-
Finance Lease Principal Payments-0.49
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities96.50
Effect of exchange rate on cash flow0.08
Discontinued operations0.00
Free Cash Flow-89.79
Total Cash Flow6.79
4 historic quarters locked

Sign in to unlock the full Alimera Sciences Inc cash flow history.

Sign In Create Free Account

About Alimera Sciences Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001267602-24-000019

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License